Affirm
AFRM
$69.94
-6.06%
Affirm Holdings, Inc. is a financial technology company that provides buy now, pay later (BNPL) solutions, enabling consumers to make purchases and pay over time through point-of-sale installment loans. As a market leader in the BNPL space, Affirm differentiates itself with transparent, interest-free options and a broad merchant network, processing over $36 billion in transaction volume in fiscal 2025. The current investor narrative centers on Affirm's accelerating revenue growth and improving profitability, as evidenced by recent earnings beats, but also on concerns about valuation and competitive pressures in the evolving consumer credit landscape.…
AFRM
Affirm
$69.94
Related headlines
Investment Opinion: Should I buy AFRM Today?
Based on the analysis, AFRM is rated a Buy. The company is delivering strong revenue growth of 32.6% YoY, has achieved profitability with a net income of $102.9M in Q3 FY2026, and has a consensus analyst target of $92.47, implying 18.9% upside. The recommendation is supported by the company's improving operating margin (19.5% in Q3 FY2026) and positive free cash flow of $787M TTM.
Sign up to view all
AFRM 12-Month Price Forecast
The AI assessment is bullish on AFRM over the next 12 months, driven by strong revenue growth, improving profitability, and positive analyst sentiment. The company's ability to generate positive net income and free cash flow reduces the risk of dilution and supports a higher valuation. However, the high P/S ratio and sensitivity to consumer credit conditions warrant caution. The stance would be upgraded to high confidence if the company maintains revenue growth above 30% and expands net margins, while a downgrade to neutral would occur if growth decelerates below 20% or credit losses spike.
Wall Street consensus
Most Wall Street analysts maintain a constructive view on Affirm's 12-month outlook, with a consensus price target around $96.54 and implied upside of +38.0% versus the current price.
Average Target
$96.54
0 analysts
Implied Upside
+38.0%
vs. current price
Analyst Count
—
covering this stock
Price Range
$55 - $124
Analyst target range
Affirm is covered by 30 analysts, with a consensus recommendation of 'Buy' and a mean recommendation score of 1.68 (where 1 is Strong Buy and 5 is Sell). The average target price is $92.47, implying an upside of approximately 18.9% from the current price of $77.76. The target range spans from $55.10 to $117.00, with the high target suggesting significant upside potential, while the low target reflects downside risks. Recent ratings actions have been mostly positive, with firms like Goldman Sachs and JP Morgan maintaining Buy/Overweight ratings, though Morgan Stanley downgraded to Equal Weight, indicating some caution.
Drowning in data?
Find the real signal!
Bulls vs Bears: AFRM Investment Factors
Affirm presents a compelling growth story with accelerating revenue, improving profitability, and a strong analyst consensus. However, the stock trades at a significant premium to its industry, and its dependence on consumer credit introduces cyclical risk. The bull case is supported by tangible financial improvements, while the bear case hinges on valuation and competitive threats. Currently, the evidence slightly favors the bulls given the strong earnings momentum and positive analyst sentiment, but the key tension is whether AFRM can sustain its growth rate to justify its premium multiple. If revenue growth decelerates or credit losses rise, the stock could face a sharp re-rating.
Bullish
- Accelerating revenue growth: Revenue grew 32.6% YoY in Q3 FY2026 to $1.04B, up from $783M in the year-ago quarter. Sequential growth from Q4 FY2025 ($876M) to Q1 FY2026 ($933M) to Q2 FY2026 ($1.12B) shows sustained momentum, driven by strong consumer demand and merchant adoption.
- Turning profitable with expanding margins: Net income turned positive at $102.9M in Q3 FY2026, a dramatic swing from a net loss of $100.2M in Q1 FY2025. Operating margin improved to 19.5% in Q3 FY2026, up from -19.0% in Q1 FY2025, demonstrating significant operating leverage.
- Strong analyst consensus and upside: 30 analysts rate AFRM a Buy with a mean score of 1.68 (1=Strong Buy). The average target price of $92.47 implies 18.9% upside from the current price of $77.76, with a high target of $117.00 suggesting even greater potential.
- Healthy balance sheet and low leverage: Debt-to-equity is only 0.21, and the current ratio is 34.1, indicating ample liquidity to fund operations and growth. This financial flexibility reduces bankruptcy risk and supports continued investment in product innovation.
Bearish
- Premium valuation vs. industry: P/S ratio of 23.8x is nearly 3x the industry average EV/Sales of 8.1x. Even with strong growth, the market is pricing in aggressive expectations, leaving little room for disappointment.
- High sensitivity to consumer credit risk: Over 70% of transaction volume comes from interest-bearing loans, exposing AFRM to potential defaults in an economic downturn. A rise in delinquencies could pressure credit losses and profitability.
- Competitive pressure from established players: BNPL competition is intensifying from Apple Pay Later, Klarna, and traditional credit card issuers. These competitors have larger balance sheets and customer bases, potentially limiting AFRM's market share growth.
- Stock underperformed over the past year: Despite the recent rally, AFRM is down 2.8% over the past year, while the S&P 500 gained 18.6%. Relative strength over 1 year is -21.3%, indicating persistent underperformance and potential investor skepticism.
AFRM Technical Analysis
Affirm's stock has exhibited a strong recovery over the past six months, with a 6-month price change of +65.5%, though it remains down 2.8% over the past year. The current price of $77.76 sits at approximately 78% of its 52-week range (between a low of $42.10 and a high of $100.00), indicating a rebound from lows but still below the peak. This positioning suggests a stock in a recovery phase, with momentum building but not yet at overbought levels.
Beta
3.62
3.62x market volatility
Max Drawdown
-53.9%
Largest decline past year
52-Week Range
$42-$93
Price range past year
Annual Return
-20.9%
Cumulative gain past year
| Period | AFRM Return | S&P 500 |
|---|---|---|
| 1m | -2.2% | +2.0% |
| 3m | +5.5% | +1.0% |
| 6m | +33.2% | +11.8% |
| 1y | -20.9% | +18.1% |
| ytd | -5.5% | +11.7% |
Bobby - Your AI Investment Partner
Get real-time data, AI-driven personalized investment analysis to make smarter investment decisions
AFRM Fundamental Analysis
Affirm's revenue trajectory is robust, with the most recent quarter (Q3 FY2026) reporting revenue of $1.04 billion, a 32.6% year-over-year increase. This growth is accelerating, as revenue has risen sequentially from $876 million in Q4 FY2025 to $933 million in Q1 FY2026, $1.12 billion in Q2 FY2026, and $1.04 billion in Q3 FY2026, indicating a strong demand environment. The company's net income turned positive, with Q3 FY2026 net income of $102.9 million, a significant improvement from a net loss of $100.2 million in Q1 FY2025, highlighting a clear path to sustained profitability.
Quarterly Revenue
$1.0B
2026-03
Revenue YoY Growth
+32.6%
YoY Comparison
Gross Margin
65.9%
Latest Quarter
Free Cash Flow
$787109000.0B
Last 12 Months
Revenue & Net Income Trends (2 Years)
Revenue Breakdown
Open an Account, get $2 TSLA now!
Valuation Analysis: Is AFRM Overvalued?
Given Affirm's positive net income, the trailing P/E ratio of 14.2x is the primary valuation metric, with a forward P/E of 16.1x, implying modest growth expectations. The stock trades at a P/S ratio of 23.8x, which is significantly higher than the industry average of 8.1x (EV/Sales), indicating a premium valuation. Historically, Affirm's P/E has ranged from negative to over 1,300x, and the current multiple is near the lower end of its historical band, suggesting the market is pricing in more conservative expectations.
PE
14.2x
Latest Quarter
vs. Historical
Low-End
5-Year PE Range 37x~82x
vs. Industry Avg
N/A
Industry PE ~N/A*
EV/EBITDA
28.4x
Enterprise Value Multiple
Investment Risk Disclosure
Financial risks include the company's reliance on continued revenue growth to justify its premium valuation. With a P/S ratio of 23.8x versus the industry's 8.1x, any slowdown in growth could trigger multiple compression. Additionally, while the company turned profitable, its net margin is still thin at 1.7% in Q3 FY2026, leaving limited buffer against rising credit losses or operating costs. The company's debt-to-equity is low at 0.21, but its interest expense of $113.8M in Q3 FY2026 is substantial relative to net income, and a rising rate environment could pressure earnings. Furthermore, free cash flow of $787M TTM is positive, but it is modest relative to the company's market cap of $27.3B, indicating that the market is pricing in significant future cash flow growth.